A hypothesis posits that glucagon resistance, a molecular phenomenon impacting glucagon’s physiological effects on glucose, amino acid (AA), and lipid metabolism, might contribute to the development of T2DM and metabolic diseases [96]. The gene discussed is GCG; the disease is metabolic disease.